Navigation Links
Cipro Has Cheaper Cousins to Treat Anthrax

Cipro, Cipro, Cipro. That's been the mantra of the media as dozens of people exposed to anthrax -- and thousands who weren't -- clamor for the potent antibiotic. But if the supply dwindles, doctors say other cheaper and widely available medications can be used, including a previous generation's wonder drug: penicillin. Although alternatives exist, Cipro is the latest and greatest, so it tends to get attention. //

It helped that Cipro was the only drug approved by the Food and Drug Administration to treat inhaled anthrax. But Health and Human Services Secretary Tommy Thompson today encouraged the use of two other antibiotics, penicillin and doxycycline. Before this month, Cipro -- the brand name for the drug ciprofloxacin -- was little known outside of doctor's offices and pharmacies, where it is dispensed to treat a variety of diseases, including urinary tract infections.

Like other antibiotics, Cipro kills harmful bacteria in the body. The main difference is that it's designed to attack a variety of types of germs. It is effective against a wide range of organisms. Doctors sometimes use Cipro when they are waiting to find out exactly what type of bacteria they're dealing with. It's especially effective against anthrax because it may take days for scientists to discover what kind of strain is involved in an attack.

According to experts, all known strains are vulnerable to Cipro, although the drug must be given before symptoms develop or shortly thereafter to be most effective. Before Cipro came along, penicillin was a common treatment for anthrax. Pharmaceutical companies say they're ready to ramp up production of anti-anthrax drugs if needed.


'"/>




Page: 1

Related medicine news :

1. Once-Daily Cipro(R) XR for Treating Complicated Urinary Tract Infections
2. Small Cars, Anti-AIDS And Anti-Cancer Drugs Would Be Cheaper
3. Cheaper Vaccines From Tomatoes To Fight HIV, Hepatitis B
4. Diabetics to get Relief from Cheaper Drugs
5. Cheaper and Quicker Alternative to Ovarian Reserve Tests
6. Cousins Recovering from His Substance Abuse Problem
7. Advances in Treatment of Cataracts
8. Recommendations for Treatment of Blood Pressue
9. New FDA Approved Drug To Treat Migraine
10. Treatment for Menieres disease
11. Treatment for pre-menstrual syndrome is ineffective
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/21/2017)... Lake City, Colo. (PRWEB) , ... April 21, 2017 , ... ... launch of the Flex House, the next project in the company’s esteemed VISION House ... to help homeowners use exactly the amount of resources they need to live affordably ...
(Date:4/21/2017)... Kong (PRWEB) , ... April 21, 2017 , ... The ... (U3DP), the first 3D printing facility among higher education institutions in Hong Kong to ... printing, in terms of the range and quantity of facilities in Hong Kong. ...
(Date:4/21/2017)... ... 2017 , ... Alive for Wellness is a group of clinical ... struggles. The Alive team uses advanced behavioral sciences treatment modalities to accomplish their ... mental health struggle is based on 10 modalities of treatment that include: ...
(Date:4/21/2017)... ... April 21, 2017 , ... Metrasens is honoured ... Trade, the UK’s most prestigious award for business success. The company has ... revenues and has grown by a total of 400% over the last six ...
(Date:4/21/2017)... ... 21, 2017 , ... BrightStar Care Salt Lake City, a home care agency ... (APCUT) and has appointed Rex Wheeler as its new Director of Business Development. “This ... and our ability to provide quality care to the community,” said Tammara Brown, owner ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017  Vanderbilt University Medical Center ... in Nashville , Tennesse have been ... Sphincter Stimulation for GERD (LESS GERD) trial. The EndoStim ... long-term reflux control by restoring normal function to the ... million people in the United States ...
(Date:4/19/2017)... 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... developing new treatments for cancer and other unmet ... previously announced underwritten public offering of 23,625,084 shares ... price of $2.00 per share, before deducting underwriting ... by Sorrento.  The net proceeds to Sorrento from ...
(Date:4/19/2017)...  New research provides evidence that an old drug may ... study released today that will be presented at the ... Boston , April 22 to 28, 2017. ... disease, the oral drug levodopa has long been considered the ... the disease progresses, the effects of the medication can partially ...
Breaking Medicine Technology: